Results 241 to 250 of about 42,703 (308)

The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia: a retrospective study from real-world data (1995-2015). [PDF]

Rheumatol Int
Almutairi KB, Inderjeeth CA, Inderjeeth CA, Preen DB, Keen HI, Nossent JC.   +5 more
europepmc   +1 more source

Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry. [PDF]

Rheumatol Ther
Harigai M, Tanaka E, Inoue E, Sakai R, Sugitani N, Toyoizumi S, Sugiyama N, Yamanaka H.   +7 more
europepmc   +1 more source

Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysis. [PDF]

RMD Open
Xie W, Hou Y, Xiao S, Zhang X, Zhang Z.
europepmc   +1 more source

Rheumatoid arthritis, disease-modifying antirheumatic drugs and risk of major osteoporotic fracture: prospective data from the HUNT Study, Norway. [PDF]

RMD Open
Tronstad I, Hoff M, Horn J, Vikjord SAA, Videm V, Johansson J, Nilsen TIL, Langhammer A.   +7 more
europepmc   +1 more source

Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database. [PDF]

Front Pharmacol
Xia S, Li YF, Raschi E, Zhang BK, Noguchi Y, Sarangdhar M, Yan M, Ma JA.   +7 more
europepmc   +1 more source

Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry. [PDF]

Arthritis Res Ther
Ochi S, Sonomoto K, Nakayamada S, Tanaka Y.   +3 more
europepmc   +1 more source

Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. [PDF]

RMD Open
Al Mohamad F, Rios Rodriguez V, Haibel H, Protopopov M, Rademacher J, Sieper J, Torgutalp M, Käding H, Proft F, Poddubnyy D.   +9 more
europepmc   +1 more source

Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study. [PDF]

PLoS One
Hai BB, Anh TL, Thi Thu PN, Van HN, Van GV, Van DH.   +5 more
europepmc   +1 more source

Correction: Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. [PDF]

RMD Open
europepmc   +1 more source